Alberto Lazarowski

2.9k total citations
71 papers, 1.8k citations indexed

About

Alberto Lazarowski is a scholar working on Oncology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alberto Lazarowski has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 24 papers in Psychiatry and Mental health and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alberto Lazarowski's work include Epilepsy research and treatment (23 papers), Drug Transport and Resistance Mechanisms (21 papers) and Pharmacological Effects and Toxicity Studies (19 papers). Alberto Lazarowski is often cited by papers focused on Epilepsy research and treatment (23 papers), Drug Transport and Resistance Mechanisms (21 papers) and Pharmacological Effects and Toxicity Studies (19 papers). Alberto Lazarowski collaborates with scholars based in Argentina, Mexico and Spain. Alberto Lazarowski's co-authors include Amalia Merelli, Jerónimo Auzmendi, Liliana Czornyj, Alberto Javier Ramos, Elena Girardi, Alicia Brusco, Gustavo Sevlever, Marisa G. Repetto, Adrián L. Rabinowicz and Carlos D’Giano and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Alberto Lazarowski

66 papers receiving 1.7k citations

Peers

Alberto Lazarowski
Shannon Dallas United States
Silvia Fossati United States
Gabriel Frampton United States
Yi Zhao Singapore
Ronald R. Fiscus United States
Shannon Dallas United States
Alberto Lazarowski
Citations per year, relative to Alberto Lazarowski Alberto Lazarowski (= 1×) peers Shannon Dallas

Countries citing papers authored by Alberto Lazarowski

Since Specialization
Citations

This map shows the geographic impact of Alberto Lazarowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Lazarowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Lazarowski more than expected).

Fields of papers citing papers by Alberto Lazarowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Lazarowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Lazarowski. The network helps show where Alberto Lazarowski may publish in the future.

Co-authorship network of co-authors of Alberto Lazarowski

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Lazarowski. A scholar is included among the top collaborators of Alberto Lazarowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Lazarowski. Alberto Lazarowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saporito-Magriñá, Christian, Elena Pastor, Fabiana Lairion, et al.. (2024). Reversal of epigenetic age and body composition improvement in consumers of resveratrol-enriched wine. 9(1). 159–168. 1 indexed citations
2.
Lairion, Fabiana, et al.. (2023). Uridine Diphosphate Glucose (UDP-G) Activates Oxidative Stress and Respiratory Burst in Isolated Neutrophils. Pharmaceuticals. 16(10). 1501–1501. 2 indexed citations
3.
Pomilio, Alicia B., Arturo A. Vitale, & Alberto Lazarowski. (2022). Uncommon Noninvasive Biomarkers for the Evaluation and Monitoring of the Etiopathogenesis of Alzheimer's Disease. Current Pharmaceutical Design. 28(14). 1152–1169. 2 indexed citations
4.
Sosa, Ezequiel, Carlos P. Modenutti, María Mercedes Palomino, et al.. (2021). From Genome to Drugs: New Approaches in Antimicrobial Discovery. Frontiers in Pharmacology. 12. 647060–647060. 30 indexed citations
5.
Auzmendi, Jerónimo, et al.. (2020). Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(4). 129522–129522. 7 indexed citations
6.
Merelli, Amalia, Alberto Javier Ramos, Alberto Lazarowski, & Jerónimo Auzmendi. (2019). Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity. Frontiers in Neuroscience. 13. 750–750. 27 indexed citations
7.
Lazarowski, Alberto, et al.. (2019). New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in mice. Epilepsy & Behavior. 121(Pt B). 106451–106451. 20 indexed citations
8.
Auzmendi, Jerónimo, Enes Akyüz, & Alberto Lazarowski. (2019). The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP). Epilepsy & Behavior. 121(Pt B). 106590–106590. 20 indexed citations
9.
Czornyj, Liliana, et al.. (2018). High incidence of persistent subtherapeutic levels of the most common AEDs in children with epilepsy receiving polytherapy. Epilepsy Research. 148. 107–114. 7 indexed citations
10.
Buendía, Jefferson Antonio, et al.. (2015). Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.. PubMed. 13(5). 441–8. 11 indexed citations
12.
Torre, Aurelio Vázquez de la, Jaume Folch, Mercè Pallàs, et al.. (2013). Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models. The International Journal of Biochemistry & Cell Biology. 45(7). 1377–1388. 37 indexed citations
13.
Merelli, Amalia, Laura Caltana, Alberto Lazarowski, & Alicia Brusco. (2011). Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia. Drug metabolism and drug interactions. 26(2). 65–69. 15 indexed citations
14.
Höcht, Christián, Alberto Lazarowski, Nèlida N. Gonzàlez, et al.. (2009). Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid. Neuroscience Letters. 453(1). 54–57. 17 indexed citations
15.
Lazarowski, Alberto, et al.. (2007). ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy. Epilepsia. 48(s5). 140–149. 175 indexed citations
16.
Höcht, Christián, Alberto Lazarowski, Nèlida N. Gonzàlez, et al.. (2007). Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model. Neuroscience Letters. 413(2). 168–172. 41 indexed citations
17.
Lazarowski, Alberto, Laura Caltana, Amalia Merelli, et al.. (2007). Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?. Journal of the Neurological Sciences. 258(1-2). 84–92. 50 indexed citations
18.
Lazarowski, Alberto, et al.. (2006). 99m Technetium-SESTAMIBI Uptake in Malignant Lymphomas. Correlation with Chemotherapy Response. Lymphatic Research and Biology. 4(1). 23–28. 5 indexed citations
19.
Rabinowicz, Adrián L., et al.. (1997). Use of Antiepileptic Drugs in Nontraumatic Neurosurgical Procedures. Clinical Neuropharmacology. 20(5). 438–441. 6 indexed citations
20.
Bonfil, R. Daniel, Eduardo Farias, Alberto Lazarowski, et al.. (1992). Expression of gelatinise/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion. Clinical & Experimental Metastasis. 10(3). 211–220. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026